BIONZ.XCCboe UK
BB Biotech AG
CHF43.70
ListedNov 2, 2012
SectorHealthcare
IndustryBiotechnology
CountrySwitzerland
Employees10
State-| CityKüsnacht| AddressSeestrasse 16| Phone41 44 2676700
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
19.1
?
Div. Rate
CHF0.00
?
Div. Yield
0.00%
?
Payout Ratio
87.34%
?
Max Consec. Div. Years
13 years
?
Longest Consec. Div.
13 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.33
?
Div. Growth Rate
25.00%
?
Score
75

Dividend History

Historical dividend payments by ex-dividend date.

Mar 23, 2026
CHF 2.2500
Mar 21, 2025
CHF 1.8000
Mar 25, 2024
CHF 2.0000
Mar 27, 2023
CHF 2.8500
Mar 21, 2022
CHF 3.8500
Mar 22, 2021
CHF 3.6000
Mar 23, 2020
CHF 3.4000
Mar 25, 2019
CHF 3.0500
Mar 15, 2018
CHF 3.3000
Mar 20, 2017
CHF 2.7500
Mar 21, 2016
CHF 2.9000
Mar 20, 2015
CHF 2.3200
Mar 21, 2014
CHF 1.4000
Mar 20, 2013
CHF 0.9000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!